You are not currently logged in.
Access JSTOR through your library or other institution:
Impact of Measles in France
Michel Rey, Josette Celers, Yves Mouton and Robert Netter
Reviews of Infectious Diseases
Vol. 5, No. 3, 1982 International Symposium on Measles Immunization (May - Jun., 1983), pp. 433-438
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4453052
Page Count: 6
Preview not available
Although measles vaccine has been licensed since 1968, immunization against measles has not met with much success in France, partly because the disease is no longer feared. The level of vaccination coverage appears to be <20%. Indeed, the present epidemiologic situation is similar to the natural situation in a developed country. A multicenter, retrospective hospital survey revealed that 1,157 patients with measles were hospitalized during a 30-month period in five areas (total population, 4.2 million). Analysis of the preliminary results of this survey and of available national data showed an incidence of 5.6-7.5 cases per 1,000 population; a hospitalization rate of one per 10,000; a death rate of 0.56 per 1 million; and a disability rate of 0.48 per 1 million. Encephalitis (the definition of which should be reappraised) occurred once in 2,850 cases, and subacute sclerosing panencephalitis was not rare (incidence, one case per 2.6 million people). The problem posed by measles is sufficiently grave to justify a national campaign urging the widespread vaccination of children.
Reviews of Infectious Diseases © 1983 Oxford University Press